Publisher correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease

Research output: Contribution to journalComment/debatepeer-review


  • Xianjun Dong
  • Zhixiang Liao
  • David Gritsch
  • Yunfei Bai
  • Joseph J. Locascio
  • Boris Guennewig
  • Ganqiang Liu
  • Cornelis Blauwendraat
  • Tao Wang
  • Charles H. Adler
  • John C. Hedreen
  • Richard L.M. Faull
  • Matthew P. Frosch
  • Peter T. Nelson
  • Patrizia Rizzu
  • Antony A. Cooper
  • Peter Heutink
  • Thomas G. Beach
  • John S. Mattick
  • Clemens R. Scherzer

External organisations

  • Southeast University
  • Harvard Medical School, Wellman Center for Photomedicine, Massachusetts General Hospital
  • University of Sydney, Austria;
  • Garvan Institute of Medical Research
  • University of New South Wales (UNSW) Australia
  • German Center for Neurodegenerative Diseases
  • Mayo Clinic Scottsdale-Phoenix, Arizona
  • McLean Hospital
  • University of Auckland
  • University of Kentucky
  • Banner Sun Health Research Institute
  • Harvard Medical School


Correction to: Nature Neuroscience, published online 17 September 2018.

In the version of this article initially published, the legends for Supplementary Figs. 4–8 and 10–14 contained errors. The Supplementary Figure legends have been corrected in the HTML and PDF versions of the article.


Original languageEnglish
Pages (from-to)144-147
Number of pages4
JournalNature Neuroscience
Issue number1
Publication statusPublished - 17 Dec 2018

ASJC Scopus subject areas